Archives

5
May

Getting Personal about Inherited Risk for Prostate Cancer

A new study published in JCO Precision Oncology by lead investigator Veda N. Giri, MD, at the Sidney Kimmel Cancer Center at Jefferson takes an important step in deciphering the genetic landscape contributing to inherited prostate cancer. Genetic Evaluation of Men (GEM) is a study focused on uncovering the genetic contribution to inherited prostate cancer. …

1
May

Dr. Veda Giri Featured on Congressional Directed Medical Research Programs Website

The research of Sidney Kimmel Cancer Center investigator Veda Giri, MD, has been highlighted on the Congressionally Directed Medical Research Programs (CDMRP) website. Giri and her team received funding from the U.S. Department of Defense Prostate Cancer Research Program (PCRP) to conduct studies on men at high risk for aggressive prostate cancer.  She and her …

28
Apr

Opening Up Chromatin for Cell Differentiation

Two new studies from the laboratory of Alex Mazo, PhD, at the Sidney Kimmel Cancer Center, along with collaborators from SKCC, the Vickie and Jack Farber Institute for Neuroscience at Thomas Jefferson University, and other institutions, provide new insights into the structure of chromatin and its implications for cellular differentiation.  The new work, appearing in …

25
Apr

New Insights into G Protein-Coupled Receptor Signaling and Regulation

A collaborative study by the laboratories of Jeffrey L. Benovic, PhD,  in the Department of Biochemistry and Molecular Biology at Thomas Jefferson University and the Sidney Kimmel Cancer Center at Jefferson, and Dr. Brian K. Kobilka in the Department of Molecular and Cellular Physiology at the Stanford University School of Medicine provides new insights into a …

5
Apr

Promising New Results in Lung Cancer Research

Investigators at the Sidney Kimmel Cancer Center at Jefferson have uncovered a new regulatory pathway with important implications for lung cancer. Lung cancer is the leading cause of all cancer-related deaths worldwide, with 85% of all cases consisting of non-small cell lung cancer (NSCLC). A major obstacle to successfully treating NSCLC  is that many patients …

30
Mar

2017 Ocular Melanoma Foundation–AACR Fellowship Awarded to Vivian Chua

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Vivian Chua, PhD, has been awarded a 2017 Ocular Melanoma Foundation–American Associate for Cancer Research (AACR) Fellowship for her project, “Novel Epigenetic Targeting Approaches in Uveal Melanoma.” This one-year, $50,000 grant recognizes the significant impact of Dr. Chua’s research, its relevance to the …

24
Mar

Noelle Williams Inducted into Gold Humanism Honor Society

The Sidney Kimmel Cancer Center at Jefferson would like to congratulate Noelle L. Williams, MD, who has been selected for induction into the Gold Humanism Honor Society Resident Chapter of Thomas Jefferson University. The Gold Humanism Honor Society recognizes students, residents, and faculty who are exemplars of compassionate patient care and who serve as role …

23
Mar

Ralph Zinner and Amy Leader Awarded ACT Research Grant from Free to Breathe

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Ralph Zinner, MD, and Amy Leader, DrPH, MPH, are the winners of the second Accelerate Clinical Trials (ACT) Research Grant Award from Free to Breathe, an organization devoted to improving the treatment and survival of lung cancer patients.  The ACT grant is a funding …

21
Mar

Unite for HER Wellness Day – April 2, 2017

  The Sidney Kimmel Cancer Center at Jefferson encourages Jefferson Hospital System breast cancer patients to participate in the upcoming “Unite for HER Wellness Day” event to be held on Sunday, April 2, 2017. This event will allow breast cancer patients to meet in a small group setting with trained professionals to learn about complementary …

15
Mar

RNA-Regulated Mechanism Validated as a Target in GI Tract Cancers

Investigators from the Sidney Kimmel Cancer Center at Jefferson, Thomas Jefferson University, and Drexel University have uncovered a critical regulatory mechanism involved in pancreatic and colorectal cancer progression. The study results were recently published in Molecular Cancer Research. The researchers investigated the role of the RNA-binding protein HuR (also known as ELAVL1) in gastrointestinal (GI) …

17
Feb

Researchers Build Pan-Cancer Biomarker Tool to Categorize Multiple Cancer Types

Researchers at the Sidney Kimmel Cancer Center at Jefferson recently discovered that isomiRs (small non-coding RNA molecules produced in a cell) are powerful enough to accurately classify samples that can belong to 32 types of cancer. The research was published in the journal Nucleic Acids Research. Work in recent years has revealed that microRNAs (miRNAs), small …

17
Feb

Five Easy Ways to Lower Your Cancer Risk

February is National Cancer Prevention Month. Below are 5 easy ways to help reduce your risk of developing cancer, thanks to Amy Leader, PhD, and Charnita Zeigler-Johnson, PhD, both Assistant Professors in the Department of Medical Oncology.  1. Healthy diet It is well known that a poor diet can lead to being overweight or obese, which …

27
Jan

The Sidney Kimmel Cancer Center at Jefferson Welcomes Pierluigi Porcu

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce the appointment of Pierluigi Porcu, MD, as the new Director of the Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Division in the Department of Medical Oncology, effective December 1, 2016. Dr. Porcu comes to Jefferson from The Ohio State University in Columbus, where he …

18
Jan

Doylestown Health Joins Sidney Kimmel Cancer Network at Jefferson

The Sidney Kimmel Cancer Network at Jefferson and Doylestown Health will officially join forces effective January 1, 2017. The affiliation combines the expertise of a leading academic medical center and a community health system with a reputation for delivering quality health care. As the newest member of the Sidney Kimmel Cancer Network (SKCN) at Jefferson, …

16
Dec

Dr. Elda Grabocka Returns to her Jefferson Roots

Elda Grabocka, PhD, feels she is back home. Dr. Grabocka, assistant professor of Cancer Biology at the Sidney Kimmel Cancer Center at Jefferson, recently authored a study: “Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules. Grabocka and her colleagues found that the same signal that drives aggressive growth in a deadly cancer cell …

21
Nov

Dr. Sara Meyer Joins Sidney Kimmel Cancer Center

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce the appointment of Sara Meyer, PhD, as a new assistant professor in the department of Cancer Biology effective November 1, 2016. Previously, Dr. Meyer was a postdoctoral fellow at Cincinnati Children’s Hospital Medical Center. Dr. Meyer received her PhD in Cell and Molecular Cancer …

26
Oct

Dr. Grace Lu-Yao Joins Jefferson

Grace Lu-Yao, PhD, MPH, recently joined the Sidney Kimmel Cancer Center at Jefferson as part of the center’s growing population science program. She is now serving as the Associate Director for Population Science at the Sidney Kimmel Cancer Center at Jefferson and the Vice Chair and professor in the department of medical oncology at the …